From: Metastatic lymph node in gastric cancer; Is it a real distant metastasis?
Clinical variables | Patient No (%) |
---|---|
Sex (Number) | Â |
   Male | 53 (67.1) |
   Female | 26 (32.9) |
Age (years) | Â |
   Median | 57 |
   Range | 25 - 75 |
ECOG performance status (Number) | Â |
   0 | 10 (12.7) |
   1 | 68 (86.1) |
   2 | 1 (1.3) |
Bormann type (Number) | Â |
   I | 0 |
   II | 17 (21.5) |
   III | 52 (65.8) |
   IV | 10 (12.7) |
Lymph node dissection (Number) | Â |
   D2 |    76 (96.2) |
   D3 | 3 (3.8) |
Lauren classification (Number) | Â |
   Intestinal | 20 (25.3) |
   Diffuse | 38 (48.1) |
   Mixed | 4 (5.1) |
   Unknown | 17 (21.5) |
Histological grade | Â |
   Well to moderate | 23 (29.1) |
   Poor to undifferentiated | 56 (70.9) |
T staging (Number) | Â |
   T1 | 0 |
   T2 | 30 (38.0) |
   T3 | 41 (51.9) |
   T4 | 8 (10.1) |
N staging (Number) | Â |
   N1 | 14 (17.7) |
   N2 | 25 (31.6) |
   N3 | 40 (50.6) |
Metastatic lymph node station (Number) | Â |
   #12 | 69 (87.3) |
   #13 | 10 (12.7) |
Post-operation treatment (Number) | Â |
   None | 21 (26.6) |
   Chemotherapy | 48 (60.8) |
   Chemo-radiation | 8 (10.1) |
   Unknown | 2 (2.5) |
Primary site (Number) | Â |
   Upper body | 9 (11.4) |
   Mid-body | 18 (22.8) |
   Lower body | 50 (63.3) |
   Whole stomach | 2 (2.5) |